1Q23 Performance Overview
GEL million
Private investment
stage portfolio
companies
EXTERNALLY VALUED
&
19
CLINICS & DIAGNOSTICS BUSINESS OVERVIEW (CONT'D)
Community Clinics
Outpatient and basic inpatient
services in regional towns and
municipalities
21%
CLINICS (1Q23)
17
Market share by number of registered patients*
Polyclinics
Outpatient diagnostic and
treatment services in Tbilisi
and major regional cities
615,700
GEORGIA
CAPITAL
DIAGNOSTICS (1Q23)
c.207,000
3.0
Number of patients served
21%
11%
c.619,000
5%
Number of tests performed
Average number of tests per
patient
GEL 6.9
Average revenue per test
(excluding COVID-19)
GHG clinics
Geo
Hospitals
319,000
279,815
Medcapital
136,000
Market share by registered patients
353
Registered patient in Tbilisi
Medison
91,000
617,293
Other
3%
20%
5%
1,675,000
60%
Retail portion in total revenue
Number of community clinics beds
Registered patient in Georgia
*As of 31-Dec-22.
NET REVENUE, CLINICS
EBITDA, CLINICS (excl. IFRS 16)
Gross profit margin (%)
EBITDA margin (%, excl. IFRS 16)
42.6%
44.8% 46.5%
44.1%
42.4%
41.6%
42.6%
15.4%
19.9%
20.1%
19.9%
13.5%
18.5%
13.4%
COVID tests portion in total
revenue
EBITDA, DIAGNOSTICS (excl. IFRS 16)
EBITDA margin (%, excl. IFRS 16)
3.2% 12.3% 23.8% 3.3% 13.7% 5.8%
70.5
65.8
-12.9%
14.1
7.3
44.2
46.3
33.3
24.9
37.8
8.9
9.4
21.0
21.4
5.9
17.9
19.6
17.1
37.2
40.9
8.6
19.9
23.2
24.9
5.6
-36.4%
9.0
3.6
1.8
1.1
2.3
0.7
0.2
0.3
-76.2%
11.0
11.4
2019 2020
2021
2022
2018
2019
2020
2021
2022
1Q22
1Q23
2018
2019
2020
2021
2022
1Q22
1Q23
1Q22 1Q23
71
Polyclinics
Community ClinicsView entire presentation